Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Amyotroph Lateral Scler Frontotemporal Degener. 2023 Mar 10;24(5-6):420–435. doi: 10.1080/21678421.2023.2173015

Figure 4. Pathogenicity classification and variant types identified using a commercially available genetic test for amyotrophic lateral sclerosis (ALS).

Figure 4.

(A) Pathogenicity classification of variants identified using a commercially available genetic test for ALS. (B) Variant types of all variants identified using a commercially available genetic test for ALS and classified as likely pathogenic or pathogenic. (C) Variant types of all variants identified using a commercially available genetic test for ALS and classified as being of uncertain significance. Abbreviations: LP, likely pathogenic; P, pathogenic; VUS, variants of uncertain significance.